Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
Hugues Chabriat, Claudio L. Bassetti, Ute Marx, Marie Laure Audoli-Inthavong, Aurore Sors, Estelle Lambert, Marine Wattez, Dirk M. Hermann, Katharina ALTHAUS, Sergi AMARO, Hee Joon BAE, Zbigniew BAK, Leonardo BARBARINI, Pietro BASSI, Rodrigo BAZAN, Daniel BERECZKI, Tomasz BERKOWICZ, Joerg BERROUSCHOT, Dylan BLACQUIERE, Waldemar BROLAKenneth BUTCHER, Pere CARDONA, Jae Kwan CHA, Geoffrey CLOUD, David COHEN, Charlotte CORDONNIER, Attila CSANYI, Anna CZLONKOWSKA, Stephen DAVIS, Jesse DAWSON, Nina DE KLIPPEL, Christian DENIER, Philippe DESFONTAINES, Hans Christoph DIENER, Peter DIOSZEGHY, Diederik Willem DIPPEL, Laura DORADO, Andras FOLYOVICH, Gabriel Rodriguez FREITAS, Mauricio Andre FRIEDRICH, Waldemar FRYZE, Rubens Jose GAGLIARDI, Marianna GOTTSCHAL, Rohan GRIMLEY, Martin GROND, Klaus GRÖSCHEL, Hassan HOSSEINI, Yangha HWANG, Bernd KALLMUENZER, Usman KHAN, Jong Sung KIM, Tim KLEINIG, Agnes KOVES, Aida LAGO MARTIN, Anetta LASEK-BAL, Giuseppe LEMBO, Robin LEMMENS, Ralf LINDERT, Luiz Carlos PORCELLO MARRONE, Maite MARTINEZ ZABALETA, Jean Louis MAS, Jaime MASJUAN VALLEJO, Mikael MAZIGHI, Cesar MINELLI, Amit MISTRI, Carlos MOLINA, Francisco MONICHE ALVAREZ, Carla Heloisa CABRAL MORO, Wim MULLENERS, Darius NABAVI, Jean Philippe NEAU, Bill O'BRIEN, Csaba OVARY, Gyula PANCZEL, Man Seok PARK, Thanh PHAN, Suzanne RAGAB, Konrad REJDAK, Christine ROFFE, Jaume ROQUER GONZALEZ, Luisa ROVER, Gisele SAMPAIO SILVA, Peter SCHELLINGER, Tomas SEGURA MARTIN, Louise SHAW, Igor SIBON, Ondrej SKODA, Didier SMADJA, Piotr SOBOLEWSKI, Hassan SODA, Nikola SPRIGG, Maciej SWIAT, Laszlo SZAPARY, Norbert SZEGEDI, Danilo TONI, Attila VALIKOVICS, Geert VANHOOREN, Laszlo VECSEI, Theodore WEIN, Andrew WONG, Alvaro XIMENEZ CARRILLO
Research output: Contribution to journal › Article › peer-review
32Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.